Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Alkermes Inc. (NASDAQ: ALKS), Wilmington, OH – FDA Inspections
Company
•United States•Public company, NASDAQ: ALKS

Alkermes Inc. (NASDAQ: ALKS), Wilmington, OH – FDA Inspections

Inspection records and compliance data for Alkermes Inc. in Wilmington, OH. Access full analysis and detailed observations. Publicly traded as NASDAQ: ALKS.

Sign in to open in Dashboard
Company Profile

This profile covers Alkermes Inc. based in Wilmington, OH, United States.

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)
  • Health Canada · 5 inspections · last September 25, 2023
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

GOJO Industries, Inc
Kutol Products Company, Inc.
Vantage Specialty Ingredients Inc.
Patheon Pharmaceuticals Inc.
Natural Essentials Inc.
West-Ward Columbus Inc.
Kao USA Inc.
AptaPharma, Inc.
Unither Manufacturing LLC
Xcelience, LLC
Company Information

Name

Alkermes Inc.

Stock ticker

ALKS

Exchange

NASDAQ

Share price

$44.63

Market cap

$7.5B

Price as of

November 6, 2026

Address

265 Olinger Circle, Wilmington, OH 45177, United States

Country

United States

ID: a1be4571-827b-4a93-a43e-a2046e607a31

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.